Multidisciplinary treatment of hepatocellular carcinoma in 2023 Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP) Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE) Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part II - Non-surgical treatments

被引：12

作者：

Cabibbo, Giuseppe ^{[1
,29
]}

Daniele, Bruno ^{[1
]}

Borzio, Mauro ^{[2
]}

Casadei-Gardini, Andrea ^{[3
]}

Cillo, Umberto ^{[4
]}

Colli, Agostino ^{[5
]}

Conforti, Massimiliano ^{[6
]}

Dadduzio, Vincenzo ^{[7
]}

Dionisi, Francesco ^{[8
]}

Farinati, Fabio ^{[9
]}

Gardini, Ivan ^{[6
]}

Giannini, Edoardo Giovanni ^{[10
]}

Golfieri, Rita ^{[11
,12
]}

Guido, Maria ^{[13
]}

Mega, Andrea ^{[14
]}

Cinquini, Michela ^{[15
,16
]}

Piscaglia, Fabio ^{[17
,18
]}

Rimassa, Lorenza ^{[19
,20
]}

Romanini, Laura ^{[21
]}

Pecorelli, Anna ^{[22
]}

Sacco, Rodolfo ^{[23
]}

Scorsetti, Marta ^{[24
,25
]}

Vigano, Luca ^{[26
,27
]}

Vitale, Alessandro ^{[5
]}

Trevisani, Franco ^{[18
,28
,30
]}

机构：

[1] Univ Palermo, Dept Hlth Promot Mother & Child Care, Sect Gastroenterol & Hepatol, Gastroenterol Unit,Azienda Osped Univ Policlin Pao, Palermo, Italy

[2] ASL Napoli Ctr 1, Osped Mare, Oncol Unit, Naples, Italy

[3] Ctr Diagnost Italiano CDI, Milan, Italy

[4] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy

[5] Padua Univ Hosp, Gen Surg Hepatopancreato Biliary Surg & Liver Tran, I-35128 Padua, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Trasfus & Ematol, Milan, Italy

[7] Italian Liver Patient Assoc, EpaC Onlus, Turin, Italy

[8] Mons AR Dimiccoli Hosp, Med Oncol Unit, ASL BT, Barletta, Italy

[9] IRCCS Regina Elena Natl Canc Inst, Dept Radiat Oncol, Rome, Italy

[10] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35128 Padua, Italy

[11] Univ Genoa, IRCCS Osped Policlin San Martino, Dept Internal Med, Gastroenterol Unit, Genoa, Italy

[12] Bologna Univ, Alma Mater Studiorum, Bologna, Italy

[13] Madre Fortunata Toniolo Private Hosp, Radiol Ctr Medipass Bologna, Radiol Unit, Bologna, Italy

[14] Univ Padua, Dept Med, Padua, Italy

[15] Reg Hosp Bolzano, Dept Gastronterol, Bolzano, Italy

[16] IRCCS, Ist Ric Farmacol Mario Negri, Oncol Dept, Milan, Italy

[17] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy

[18] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[19] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Pieve Emanuele, Milan, Italy

[20] IRCCS Humanitas Res Hosp, Med Oncol & Hematol Unit, Via Manzoni 56, I-20089 Milan, Italy

[21] ASST Cremona, Osped Cremona, Radiol Unit, Cremona, Italy

[22] IRCCS Azienda Osped Univ Bologna, Dept Radiol, Bologna, Italy

[23] Univ Foggia, Dept Surg & Med Sci, Gastroenterol & Endoscopy Unit, I-71100 Foggia, Italy

[24] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Milan, Italy

[25] Humanitas Res Hosp IRCCS, Dept Radiotherapy & Radiosurg, Via Manzoni 56, I-20089 Rozzano, Milan, Italy

[26] Humanitas Gavazzeni Univ Hosp, Dept Minimally Invas Gen & Oncol Surg, Hepatobiliary Unit, Viale M Gavazzeni 21, I-24125 Bergamo, Italy

[27] IRCCS Azienda Osped Univ Bologna, Unit Semeiot, Liver & Alcohol Related Dis, I-40138 Bologna, Italy

[28] Humanitas Univ, Dept Biomed Sci, Viale Rita Levi Montalcini 4, I-20090 Milan, Italy

[29] Univ Palermo, Dept Hlth Promot Mother & Child Care, Sect Gastroenterol & Hepatol, Internal Med & Med Specialties PROMISE, Piazza Clin 2, I-90127 Palermo, Italy

[30] IRCCS Azienda Osped Univ Bologna, Unit Semeiot Liver & Alcohol related Dis, I-40138 Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷 / 03期

关键词：

GRADE; Guideline; Hepatocellular carcinoma; Immunotherapy; Liver cancer; Multidisciplinary board; Survival; Systemic therapy; ATEZOLIZUMAB PLUS BEVACIZUMAB; BEAD TRANSARTERIAL CHEMOEMBOLIZATION; STEREOTACTIC BODY RADIOTHERAPY; DOXORUBICIN-ELUTING BEADS; COST-EFFECTIVENESS; RADIOFREQUENCY ABLATION; CONVENTIONAL CHEMOEMBOLIZATION; OPEN-LABEL; ARTERIAL CHEMOEMBOLIZATION; Y-90; RADIOEMBOLIZATION;

D O I：

10.1016/j.dld.2023.10.028

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer -related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of its management. Following the need to have updated guidelines on the multidisciplinary treatment management of HCC, the Italian Scientific Societies involved in the management of this cancer have promoted the drafting of a new dedicated document. This document was drawn up according to the GRADE methodology needed to produce guidelines based on evidence. Here is presented the second part of guidelines, focused on the multidisciplinary tumor board of experts and non -surgical treatments of HCC. (c) 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

引用

页码：394 / 405

页数：12

共 112 条

[41] Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
Galle, Peter R.
Finn, Richard S.
Qin, Shukui
Ikeda, Masafumi
Zhu, Andrew X.
Kim, Tae-You
Kudo, Masatoshi
Breder, Valeriy
Merle, Philippe
Kaseb, Ahmed
Li, Daneng
Mulla, Sohail
Verret, Wendy
Xu, Derek-Zhen
Hernandez, Sairy
Ding, Beiying
Liu, Juan
Huang, Chen
Lim, Ho Yeong
Cheng, Ann-Lii
Ducreux, Michel
[J]. LANCET ONCOLOGY, 2021, 22 (07) : 991 - 1001
[42] Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
Gardini, Andrea Casadei
Tamburini, Emiliano
Inarrairaegui, Mercedes
Frassineti, Giovanni Luca
Sangro, Bruno
[J]. ONCOTARGETS AND THERAPY, 2018, 11 : 7315 - 7321
[43] The changing scenario of hepatocellular carcinoma in Italy: an update
Garuti, Francesca
Neri, Andrea
Avanzato, Francesca
Gramenzi, Annagiulia
Rampoldi, Davide
Rucci, Paola
Farinati, Fabio
Giannini, Edoardo G.
Piscaglia, Fabio
Rapaccini, Gian Ludovico
Di Marco, Maria
Caturelli, Eugenio
Zoli, Marco
Sacco, Rodolfo
Cabibbo, Giuseppe
Marra, Fabio
Mega, Andrea
Morisco, Filomena
Gasbarrini, Antonio
Svegliati-Baroni, Gianluca
Foschi, Francesco G.
Missale, Gabriele
Masotto, Alberto
Nardone, Gerardo
Raimondo, Giovanni
Azzaroli, Francesco
Vidili, Gianpaolo
Brunetto, Maurizia R.
Trevisani, Franco
[J]. LIVER INTERNATIONAL, 2021, 41 (03) : 585 - 597
[44] Prognosis of Untreated Hepatocellular Carcinoma
Giannini, Edoardo G.
Farinati, Fabio
Ciccarese, Francesca
Pecorelli, Anna
Rapaccini, Gian Lodovico
Di Marco, Mariella
Benvegnu, Luisa
Caturelli, Eugenio
Zoli, Marco
Borzio, Franco
Chiaramonte, Maria
Trevisani, Franco
[J]. HEPATOLOGY, 2015, 61 (01) : 184 - 190
[45] Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Giannini, Edoardo Giovanni
Bucci, Laura
Garuti, Francesca
Brunacci, Matteo
Lenzi, Barbara
Valente, Matteo
Caturelli, Eugenio
Cabibbo, Giuseppe
Piscaglia, Fabio
Virdone, Roberto
Felder, Martina
Ciccarese, Francesca
Foschi, Francesco Giuseppe
Sacco, Rodolfo
Baroni, Gianluca Svegliati
Farinati, Fabio
Rapaccini, Gian Lodovico
Olivani, Andrea
Gasbarrini, Antonio
Di Marco, Maria
Morisco, Filomena
Zoli, Marco
Masotto, Alberto
Borzio, Franco
Benvegnu, Luisa
Marra, Fabio
Colecchia, Antonio
Nardone, Gerardo
Bernardi, Mauro
Trevisani, Franco
[J]. HEPATOLOGY, 2018, 67 (05) : 1784 - 1796
[46] Single-center randomized trial comparing conventional chemoembolization versus doxorubicin-loaded polyethylene glycol microspheres for early- and intermediate-stage hepatocellular carcinoma
Gjoreski, Aleksandar
Jovanoska, Ivona
Risteski, Filip
Veljanova, Biljana Prgova
Nedelkovski, Dane
Dimov, Vladimir
Jovanovska, Rozalinda Popova
Angelovska, Biljana Grozdanovska
Mitrevski, Nenad
Dimova, Biljana
[J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2021, 30 (03) : 258 - 266
[47] Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
Golfieri, R.
Giampalma, E.
Renzulli, M.
Cioni, R.
Bargellini, I.
Bartolozzi, C.
Breatta, A. D.
Gandini, G.
Nani, R.
Gasparini, D.
Cucchetti, A.
Bolondi, L.
Trevisani, F.
[J]. BRITISH JOURNAL OF CANCER, 2014, 111 (02) : 255 - 264
[48] Experience with regorafenib in the treatment of hepatocellular carcinoma
Granito, Alessandro
Forgione, Antonella
Marinelli, Sara
Renzulli, Matteo
Ielasi, Luca
Sansone, Vito
Benevento, Francesca
Piscaglia, Fabio
Tovoli, Francesco
[J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
[49] GreenS, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 Updated March 2011
[50] GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, Gordon H.
Oxman, Andrew D.
Vist, Gunn E.
Kunz, Regina
Falck-Ytter, Yngve
Alonso-Coello, Pablo
Schuenemann, Holger J.
[J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7650): : 924 - 926

← 1 2 3 4 5 6 7 8 9 10 →